PRIMARY CILIARY DYSKINESIA (PCD)
Clinical trials for PRIMARY CILIARY DYSKINESIA (PCD) explained in plain language.
Never miss a new study
Get alerted when new PRIMARY CILIARY DYSKINESIA (PCD) trials appear
Sign up with your email to follow new studies for PRIMARY CILIARY DYSKINESIA (PCD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
First-in-Human trial tests inhaled gene therapy for rare lung disease
Disease control OngoingThis early-stage study is testing an inhaled gene therapy called RCT1100 in adults with Primary Ciliary Dyskinesia (PCD) caused by specific DNAI1 gene mutations. The trial aims to see if the treatment improves mucus clearance from the lungs and is safe for participants. Researche…
Matched conditions: PRIMARY CILIARY DYSKINESIA (PCD)
Phase: PHASE1 • Sponsor: ReCode Therapeutics • Aim: Disease control
Last updated Apr 02, 2026 03:57 UTC
-
Cleaner air at home: a new hope for rare lung diseases?
Disease control ENROLLING_BY_INVITATIONThis study is testing whether using HEPA air purifiers at home can help people with cystic fibrosis (CF) or primary ciliary dyskinesia (PCD) breathe easier. Researchers will give 62 participants in Cyprus two air purifiers for their homes and track their lung function, symptoms, …
Matched conditions: PRIMARY CILIARY DYSKINESIA (PCD)
Phase: NA • Sponsor: University of Cyprus • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC